BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8208350)

  • 1. Inherited or acquired disorders of blood coagulation in children with neurovascular complications.
    Göbel U
    Neuropediatrics; 1994 Feb; 25(1):4-7. PubMed ID: 8208350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent venous thrombosis and hypercoagulable states.
    Bolan CD; Alving BM
    Am Fam Physician; 1991 Nov; 44(5):1741-51. PubMed ID: 1835274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary antithrombin III deficiency and venous thrombosis.
    Michiels JJ; Van Vliet HH
    Neth J Med; 1984; 27(6):226-32. PubMed ID: 6379481
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation disorders in children].
    Kurnik K
    Hamostaseologie; 2008 Dec; 28(5):465-71. PubMed ID: 19132176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral thromboembolism due to antithrombin III deficiency in two children.
    Vomberg PP; Breederveld C; Fleury P; Arts WF
    Neuropediatrics; 1987 Feb; 18(1):42-4. PubMed ID: 3561706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome.
    Onyemelukwe GC; Jibril HB
    Trop Geogr Med; 1992 Jan; 44(1-2):37-41. PubMed ID: 1496720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural anticoagulants as a cause of hereditary familial thrombosis].
    Tripodi A; Mannucci PM
    Haematologica; 1990; 75 Suppl 2():1-5. PubMed ID: 2143743
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiphospholipid antibodies and the central nervous system].
    Bodiguel E
    Rev Neurol (Paris); 1992; 148(11):655-62. PubMed ID: 1303554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis.
    Bonduel M; Sciuccati G; Hepner M; Torres AF; Pieroni G; Frontroth JP
    Arch Neurol; 1999 Aug; 56(8):967-71. PubMed ID: 10448802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies in children.
    Manco-Johnson MJ
    Semin Thromb Hemost; 1998; 24(6):591-8. PubMed ID: 10066155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental hemostasis: relevance to hemostatic problems during childhood.
    Andrew M
    Semin Thromb Hemost; 1995; 21(4):341-56. PubMed ID: 8747697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited hypercoagulable states in children.
    Whitlock JA; Janco RL; Phillips JA
    Am J Pediatr Hematol Oncol; 1989; 11(2):170-3. PubMed ID: 2526603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke.
    de Lau LM; Leebeek FW; de Maat MP; Koudstaal PJ; Dippel DW
    Int J Stroke; 2010 Oct; 5(5):385-94. PubMed ID: 20854623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical implications of antithrombin III deficiency.
    Karl R; Garlick I; Zarins C; Cheng E; Chediak J
    Surgery; 1981 Apr; 89(4):429-33. PubMed ID: 7209791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital coagulopathies in the pediatric population.
    Srnec P
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):445-52. PubMed ID: 8217040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1985 Sep; 33(9):974-81. PubMed ID: 3841167
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of the hemostasis laboratory in the etiologic approach to deep vein thrombosis].
    De Maistre E; Briquel ME; Andre E; Regnault V; Whal D; Perret C; Laprevote MC; Lecompte T
    J Mal Vasc; 1996; 21(1):1-6. PubMed ID: 8656085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.